Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4
Molecular Cell · 2026
DOI: 10.1016/j.molcel.2026.08.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Chen Chu und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical Schoo…. Hauptthemen laut MEDLINE: Cyclin E, Cyclin-Dependent Kinase 2, Cell Cycle Proteins, Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, Cancer Research Institute, Kosciuszko Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA; Systems, Synthetic, and Quantitative Biology Pr…
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02215, USA.
- Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.
- Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
- Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA.
Förderung
- National Institutes of Health
- Cancer Research Institute
- Kosciuszko Foundation
- Sara Elizabeth O'Brien Trust
- National Cancer Institute
- National Cancer Center
Zitieren
APA
Chu, C., Zheng, S., Mitchell, N., Li, Z., Zhang, X., Wu, X., Zhang, T., Dang, F., Michowski, W., Kolodziejczyk, A., Xu, M. L., Kotowski, K. W., Yang, Z., Martinez-Alonso, D., Paulo, J., Sheng, J., Kirby, J. A., Groezinger, F., Zhou, Y., …, & Sicinski, P. (2026). Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.08.007
Vancouver
Chu C, Zheng S, Mitchell N, Li Z, Zhang X, Wu X, et al. Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.08.007
BibTeX
@article{Chu2026,
author = {Chu, Chen and Zheng, Shanshan and Mitchell, Ning and Li, Zheqi and Zhang, Xixi and Wu, Xiaowei and Zhang, Tian and Dang, Fabin and Michowski, Wojciech and Kolodziejczyk, Aleksandra and Xu, Miranda L and Kotowski, Krzysztof W and Yang, Zhe and Martinez-Alonso, Diego and Paulo, Joao and Sheng, Jindan and Kirby, Jane A and Groezinger, Finn and Zhou, Yubin and He, Miao and Ito, Yoshinaga and Gulvady, Anushree C and Cole, Michael I and Foidart, Pierre and Nishida, Jun and Ning, Xiaohan and Sharma, Samanta and Suski, Jan M and Fassl, Anne and Zhou, Yu and Geng, Yan and Wei, Wenyi and Gygi, Steven P and Polyak, Kornelia and Wucherpfennig, Kai W and Sicinski, Piotr},
title = {Cyclin E-CDK2 regulates cancer cell transcriptional program and response to immunotherapy through BRD4},
journal = {Molecular Cell},
year = {2026},
doi = {10.1016/j.molcel.2026.08.007}
}
EUVIMED